Hepcidin predicts 5-year mortality after community-acquired pneumonia
暂无分享,去创建一个
T. Ueland | P. Aukrust | C. Brede | E. Husebye | Ø. Skadberg | A. Michelsen | J. Holter | L. Heggelund | Trude Steinsvik | William W Siljan | T. Steinsvik | Kjersti Oppen | W. Siljan
[1] T. Ueland,et al. Hepcidin and Ferritin Predict Microbial Etiology in Community-Acquired Pneumonia , 2021, Open forum infectious diseases.
[2] Özlem Acicbe,et al. The relationship between serum erythropoietin, hepcidin, and haptoglobin levels with disease severity and other biochemical values in patients with COVID‐19 , 2021, International journal of laboratory hematology.
[3] L. Silvestri,et al. Hepcidin levels predict Covid‐19 severity and mortality in a cohort of hospitalized Italian patients , 2020, American journal of hematology.
[4] O. Franco,et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis , 2020, European Journal of Epidemiology.
[5] Ying Guo,et al. Association of inflammatory markers with the severity of COVID-19 , 2020, medRxiv.
[6] W. März,et al. Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study). , 2019, Clinical chemistry.
[7] Yi Jiang,et al. Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: a preliminary observational study , 2019, Annals of Intensive Care.
[8] T. Ganz,et al. Anemia of inflammation. , 2019, Blood.
[9] A. Mebazaa,et al. Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients , 2018, Critical Care.
[10] Shan-you Hu,et al. Serum iron levels are an independent predictor of in-hospital mortality of critically ill patients: a retrospective, single-institution study , 2018, The Journal of international medical research.
[11] T. Ueland,et al. Cytokine responses, microbial aetiology and short‐term outcome in community‐acquired pneumonia , 2017, European journal of clinical investigation.
[12] D. Girelli,et al. Hepcidin in the diagnosis of iron disorders. , 2016, Blood.
[13] F. Tacke,et al. Iron Parameters Determine the Prognosis of Critically Ill Patients* , 2016, Critical care medicine.
[14] A. Simonetti,et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: A systematic review and meta-analysis. , 2016, The Journal of infection.
[15] S. Frøland,et al. Risk Factors for Long-Term Mortality after Hospitalization for Community-Acquired Pneumonia: A 5-Year Prospective Follow-Up Study , 2016, PloS one.
[16] S. Frøland,et al. Etiology of community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway , 2015, BMC Infectious Diseases.
[17] M. Muckenthaler,et al. Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB , 2014, Gut.
[18] A. Prentice,et al. Hepcidin and the Iron-Infection Axis , 2012, Science.
[19] D. Musher,et al. Anemia and community-acquired pneumococcal pneumonia , 2011, Infection.
[20] M. Christ-Crain,et al. Inflammatory responses predict long-term mortality risk in community-acquired pneumonia , 2010, European Respiratory Journal.
[21] D. Angus,et al. The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia , 2010, BMC pulmonary medicine.
[22] D. Swinkels,et al. Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. , 2007, Clinical chemistry.
[23] W. Lim,et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study , 2003, Thorax.
[24] M. Fine,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.
[25] T. Ganz. Iron and infection , 2017, International Journal of Hematology.